Participated · Seed · Jan 2026

Yuki has built Yuki Fabric, an optimization AI model that sits above an organization’s data stack and continuously analyzes workload behavior, SLAs and cost-performance trade-offs to route each query to the most efficient compute resource in real time. The metadata-only platform integrates with Snowflake, Google BigQuery and Iceberg-based data lakes, acting as the missing control plane for next-generation data architectures. Customers such as Tenable and Angel Studios have reported average data-cost savings of 42.6%, and Yuki charges a usage-based fee tied directly to the savings it generates. Founded in 2025 by CEO Ido Arieli Noga and CTO Amir Peres, the company employs 15 people—mostly in Israel, with additional staff in the U.S. and U.K. The newly unveiled funds will expand the Israeli R&D center, add support for more data platforms and grow the U.S. sales organization. Yuki targets the $9.8 billion cloud-management tools market, positioning itself as a cost-reduction and governance solution as AI workloads proliferate across enterprises.

Participated · Series A · Nov 2025

Majestic Labs is an Israel-based hardware startup designing servers purpose-built for artificial intelligence workloads. Its flagship system collapses what would normally be multiple racks of equipment into a single server by pairing custom accelerator and memory-interface chips that separate memory from compute. The architecture delivers up to 128 TB of fast, power-efficient, high-bandwidth memory per server, enabling enterprises to run very large AI models while cutting power usage, data-center space, and infrastructure costs. The company was founded by Ofer Schacham, Masumi Reynders, and Sha Rabii. With fresh capital, management plans to grow its roster of AI data-science, software, silicon, and systems engineers and push the product toward general availability. No operating metrics such as revenue or user counts were disclosed.

Participated · Series C · Oct 2025

Founded in 2015, Omnix Medical is focused on discovering and developing novel antimicrobial peptide (AMP) therapies that address life-threatening, antibiotic-resistant infections. Its lead candidate, OMN6, rapidly destroys bacterial cell membranes and has received Fast-Track and Qualified Infectious Disease Product designations from the U.S. FDA. The company is currently running Phase II proof-of-concept trials targeting Gram-negative pathogens such as Acinetobacter baumannii, a major cause of hospital-acquired infections. Proceeds from recent funding will also support regulatory preparations, manufacturing scale-up, and advancement of additional AMP candidates in the pipeline. Unlike traditional antibiotics that target specific bacterial functions, OMN6’s pore-forming mechanism minimizes the chance of resistance development. Since inception, Omnix Medical has raised a total of $43 million to finance its R&D and clinical programs.

Participated · Seed · Jul 2025

Octup offers a real-time AI operations platform that connects to Warehouse Management Systems (WMS), Enterprise Resource Planning (ERP) systems, and shipping services to provide unified operational data, real-time analytics, and client portals. The product is designed to enhance visibility and trust between 3PLs and their clients and to replace traditionally manual processes. Octup positions itself as a data-driven operating system for logistics, targeting modernization of the global 3PL market. The company plans to use the new funding to accelerate AI-powered product development and expand its presence in North America. Octup also intends to triple its workforce to support growth. The company recently appointed Dror Feldheim, co-founder of Trax, as Chairman of the Board to guide its global operations expansion. Octup offers a 360-degree prescriptive discovery platform that gathers, interprets, and correlates data from every facet of ecommerce operations. The platform is designed to provide complete operational visibility, reveal hidden costs, and prescribe actions to improve performance. Octup serves a global customer base across apparel, supplements, consumer electronics, skincare, cosmetics, and jewelry. The company says clients using its solution have seen overall profits increase by up to 40%. Led by CEO and founder Alon Partuk, Octup intends to use new funding to broaden rollout of its end-to-end discovery platform.

Participated · Series A · Jul 2025

Deeto is an AI-native platform that continuously collects, organizes, and surfaces real customer stories and insights to build trust and accelerate buyer decisions. The product automatically matches customer-proof content to buyer personas and embeds that intelligence across CRMs, websites, and sales enablement tools. Deeto emphasizes minimal lift from Sales, Marketing, or Customer Success while delivering personalized customer voice at scale. The company counts customers such as Atlassian, Dropbox, Klaviyo, Bloomreach, and 6Sense. Deeto is headquartered in New York City and is led by Co-Founder and CEO Eran Baron. Financially, the company has raised $17 million to date, including the newly announced Series A.